A Single-arm, Multi-center, Open Clinical Study of Avatrombopag on the Treatment of Thrombocytopenia Induced by Chemotherapy of Malignant Tumors
Latest Information Update: 04 May 2022
At a glance
- Drugs Avatrombopag (Primary)
- Indications Chemotherapy-induced damage; Thrombocytopenia
- Focus Therapeutic Use
- 24 Apr 2022 Status changed from recruiting to completed.
- 03 Nov 2020 New trial record